Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Resource
Hepatogastroenterology,51(57),815-819.
Journal
Hepatogastroenterology
Journal Volume
51
Journal Issue
57
Pages
815-819
Date Issued
2004-05
Date
2004-05
Author(s)
Lu, YS
Hsu, C
Li, CC
Kuo, SH
Kun-Huei, Yeh
Yang, CH
Hsu, CH
Wu, CY
Cheng, AL.